Clinical Trial Update: Islet Transplantation Using Campath-1H and Infliximab Induction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating islet transplantation using Campath-1H (alemtuzumab) and infliximab induction for Type 1 diabetes mellitus; the study status w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Campath-1H (alemtuzumab)
• Infliximab (infliximab)

Snippet

Sponsor: University of Alberta | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED